Le Lézard
Classified in: Science and technology
Subject: Conference

Klaviyo to Present at Upcoming Investor Conferences


Klaviyo (NYSE: KVYO), the company that powers smarter digital relationships, today announced its planned participation at two upcoming conferences:

Live webcasts and replays will be available on the Company's investor relations website at https://investors.klaviyo.com/.

About Klaviyo

Klaviyo (CLAY-vee-oh) powers smarter digital relationships, making it easy for businesses to capture, store, analyze, and predictively use their own data to drive measurable, high-value outcomes. Klaviyo's modern and intuitive SaaS platform enables business users of any skill level to harness their first-party data from more than 350 integrations to send the right message at the right time across email, SMS, and push notifications. Innovative businesses like Good American, TaylorMade, Skims, Stanley 1913, and more than 143,000 other paying customers leverage Klaviyo to acquire, engage, and retain customers?and grow on their own terms.

Tag: IR


These press releases may also interest you

at 07:28
Huawei will launch a new self-developed painting app for tablets called GoPaint. Huawei's official account also kicked off the warm-up of the GoPaint app and noted "Creation begins here! The powerful-ever Huawei-developed app GoPaint is coming, see...

at 07:25
On April 29, 2024, SK Telecom Co., Ltd. filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission. The 2023 Annual Report on Form 20-F can be viewed on www.sktelecom.com, as well as...

at 07:10
POSaBIT Systems Corporation (the "Company" or "POSaBIT") announces today that the Company is anticipating a delay in filing its annual financial statements and accompanying management's discussion and analysis for the year ended December 31, 2023...

at 07:06
Recently, at Auto China 2024, Neusoft Corporation (Neusoft, SSE:600718) launched OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0, showcasing its innovative achievements in the AI+ Automotive field. It's also one of the series of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...



News published on and distributed by: